Galmed Pharmaceuticals (GLMD) Tax Provisions (2013 - 2018)

Galmed Pharmaceuticals (GLMD) recorded quarterly Tax Provisions of $75000.0 in Q3 2018, down 28.57% quarter-over-quarter from $105000.0 in Q3 2016.

Galmed Pharmaceuticals (GLMD) Tax Provisions (2013 - 2018) Analysis & Trends

Galmed Pharmaceuticals' Tax Provisions history runs 3 years deep, the most recent figure standing at $75000.0 for Q3 2018.

In Q3 2018, Tax Provisions changed N/A year-over-year to $75000.0; the TTM figure through Dec 2018 stood at $75000.0 (changed N/A YoY), while the FY2024 annual figure was $22000.0, up 37.5% from the prior year.
Tax Provisions was $75000.0 for Q3 2018 at Galmed Pharmaceuticals, down from $105000.0 in the prior quarter.
In the past five years, Tax Provisions ranged from a high of $105000.0 in Q3 2016 to a low of $1000.0 in Q2 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-11.20 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	216,000.00
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-859,000.00
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	221.50 Mn
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Galmed Pharmaceuticals	2.48 Mn	-1.63 Mn	-	-

Download Data